Cumulative effect of lead on cognition
Is bone more revealing than blood?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
There is abundant evidence that high levels of lead in blood can have adverse health—including neurologic—outcomes both among children and adults.1 Because of this, to protect the health of workers—some of whom can experience very high exposure levels—the Occupational Health and Safety Administration (OSHA) standard for lead dictates that workers with blood lead concentration higher than 60 μg/dL be removed from work and that they cannot return until their blood lead levels return below 40 μg/dL. These rules make sense, but they do not tell the whole story. The half-life of lead in blood is about 1 month. Thus, blood lead provides an indication of relatively recent exposures, but does not reflect cumulative exposure well. What happens when people are exposed to lead—even low levels, well below OSHA blood lead limits, that most of us might experience in our lives, from, for example, lead in gasoline, paint, or water pipes—for a long period of time?
The article in this issue of Neurology by Shih et al.2 is a major contribution to our understanding of the cognitive effects of cumulative exposure to lead among community-dwelling adults—as distinct from former lead …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workersW.F. Stewart, B.S. Schwartz, D. Simon et al.Neurology, May 01, 1999 -
Articles
Environmental lead exposure and cognitive function in community-dwelling older adultsR. A. Shih, T. A. Glass, K. Bandeen-Roche et al.Neurology, September 13, 2006 -
Article
Differential contribution of current and cumulative indices of lead dose to neuropsychological performance by ageMargit L. Bleecker, Karen N. Lindgren, Patrick D. Ford et al.Neurology, March 01, 1997 -
Articles
Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performanceM. L. Bleecker, D. P. Ford, M. A. Celio et al.Neurology, July 30, 2007